VEON Ltd.
VEONVEON Ltd.'s earnings have outrun its stock. EPS grew +30.4% in a year against a +7.5% price move.
Biggest watch item: margins are the best this company has ever printed — every ratio flatters at record profitability, so the whole story leans on margins holding.
The price is in a confirmed uptrend (2 weeks in). Underneath, the last four quarters read improving — profit +0.0% year on year, and 316% of the last 3 years' profit arrived as cash. What settles it: the next one or two quarters of delivery.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
VEON Ltd. trades at $54.3, in a confirmed uptrend and 2 weeks into that stage. That is +4.7% against its own 200-day average. It sits at 71% of a 52-week range of $44 to $59. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 2 straight weeks.
Today the stock is in a confirmed uptrend — week 2 of stage 2. At $54.3 it trades +4.7% versus its 200-day average and sits at 71% of its 52-week range ($44–$59).
Against the market, two honest reads. Cumulative: over the last 10.1 years the stock moved −46% while the S&P 500 moved +263% — behind the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 2 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
VEON Ltd. trades at 63.9× P/E, against too little history to rank. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 63.9× is against too little history to rank. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +30.4% against a +7.5% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 3y, of the +46.7%/yr price move, ~+7.6%/yr came from earnings growth and ~+39.1 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
VEON Ltd. reads as mixed on its fundamental arc. Mixed — no clean majority across the growth curves, ROCE lifting at 16.0% — the per-curve reads carry the story. The read is built from 12 quarters across 3 curves, on partial evidence.
Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +10.0% | +5.5% | — | — |
| Profit | +20.4% | −6.9% | — | — |
| EPS | +30.4% | — | — | — |
| Stock price | +7.5% | +46.7% | +4.3% | −6.9% |
4-Factor Sector Score
54.4/100 — rank 3 of 21 in Telecom Services · 58% evidence confidence
VEON Ltd. scores 54.4 out of 100 against the 21 companies it is compared with in Telecom Services, ranking 3. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 15.4 + 16.4 + 8.7 + 13.9 = 54.4. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
VEON Ltd. reported $1.2 B of revenue in the Mar 26 quarter, +16.5% year on year. That is the 11th straight quarter of year-on-year growth. Over 4 years it has compounded at 3.4% a year. The last full year, FY25, came in at $4.4 B. The last four reported quarters add to $4.6 B.
FY25 revenue came in at $4.4 B (+10.0% on the year), capping 4 years at 3.4% compound. The latest quarter (Mar 26) printed $1.2 B, +16.5% year on year — the 11th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +11.5% growth against the decade's 3.4% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +11.5% over the last 4 quarters against +10.4%/yr over the last 8 — stabilising; TTM profit +10.6% vs +86.2%/yr — rolling over.
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
VEON Ltd.'s operating margin is 25.8% in the Mar 26 quarter, +2.5 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 5 fiscal years the operating margin has ranged 25.1% to 32.7%. The current quarter sits inside that band.
The latest quarter's operating margin is 25.8%, +2.5 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 25.1%–32.7%, and FY25's 32.7% is the top of that band — a record year.
Why the margin moved: operating margin went +2.5 pp year on year while gross margin went +0.1 pp — the gain came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
VEON Ltd. earned $0.1 B of net profit in the Mar 26 quarter, +0.0% year on year. Full-year FY25 profit was $0.6 B. The 4-year compound rate is 48.9%. That is 10.0% of the quarter's revenue. The same quarter a year earlier earned $0.1 B. 1 of the last 12 reported quarters were loss-making.
Mar 26 profit was $0.1 B, +0.0% year on year. On the full year, FY25 printed $0.6 B (+20.4%), and the 4-year compound rate is 48.9%.
🚨 Why profit moved: revenue contributed +16.5% and the margin +2.5 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.
Pace comparison, last four quarters: profit +105.1% vs revenue +11.5%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra dollar of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 316% of VEON Ltd.'s reported profit arrived as operating cash — the cash follows the profit. In FY25 that was $1.4 B of operating cash against $0.6 B of profit. After $0.7 B of capital spending, $0.6 B was left as free cash.
FY25: operating cash of $1.4 B against reported profit of $0.6 B, leaving free cash of $0.6 B after $0.7 B of capital spending. Across the last 3 fiscal years the conversion rate is 316% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
VEON Ltd. does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $2.0 B over the last 3 years. Averaged over those years that is 15.2% of FY25 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of $2.0 B over the last 3 fiscal years.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
VEON Ltd. earns a ROE of 36% in FY25. That is up from a trough of 8% in FY21. Return on invested capital clears the cost of that capital by +1.6 percentage points, so growth here adds value rather than only size. The wiring behind it is 13.4% net margin on 0.48× asset turns.
FY25 ROE is 36%, recovered from a FY21 trough of 8% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY25): 13.4% net margin × 0.48× asset turns × 5.65× balance-sheet leverage ≈ 36.3% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 9.0% − 7.4% = a +1.6 pp spread. The 7.4% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. Positive but thin — value creation with little room for error.
Dividend
VEON Ltd. pays no dividend. Across the last 12 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.
VEON Ltd. does not currently pay a dividend. Across the last 12 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
VEON Ltd. carries total debt of $5.8 B against shareholder equity of $1.9 B as of Jun 26, a debt-to-equity of 3.05. On the annual view that ratio went from 7.10 in FY21 to 3.15 in FY25. Read the returns elsewhere on this page with that leverage in mind.
Jun 26: total debt of $5.8 B against shareholder equity of $1.9 B — a debt-to-equity of 3.05. On the annual view, debt-to-equity went from 7.10 (FY21) to 3.15 (FY25). Read the returns on this page with that leverage in mind.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
No ownership or positioning reading is held for VEON Ltd., so this section names the gap rather than filling it. At typical trading volumes those positions would take about 2.4 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
We hold no ownership or positioning reading for this stock, so this section says that plainly.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
VEON Ltd.: the Z-score reads 0.70. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits inside the distress zone. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
🚨 Why it matters: a Z-score of 0.70 is inside the distress zone — the balance sheet is a real risk, not a detail.
The safety line in one sentence: the Z-score reads 0.70.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1BCE Inc.BCE | 59.1/100Mixed-positive evidence81% evidence | BASING | 23.4/35 Revenue 1.6% · PAT 100% · OPM change 3.3 pp 83% evidence | 12.0/25 ROCE 2% · OPM 20.7% 76% evidence | 15.7/20 P/E 5.2× · PEG 0.15 65% evidence | 8.0/20 RS sector -9.8% · RS bench -17.7% · 1Y -9.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 23.4 + 12 + 15.7 + 8 = 59.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Millicom International Cellular S.A.TIGO | 56.5/100Mixed-positive evidence71% evidence | LEADER | 15.8/35 Revenue 13.1% · PAT 17.3% · OPM change -8.3 pp 83% evidence | 13.0/25 ROCE 3.2% · OPM 21.5% 76% evidence | 9.9/20 P/E 10.2× · PEG — 15% evidence | 17.8/20 RS sector 37.1% · RS bench 25.1% · 1Y 120.8%9 of 12 weeks ahead 100% evidence |
| Exact sum: 15.8 + 13 + 9.9 + 17.8 = 56.5 · Decision use: Price leads the evidence: RS versus the benchmark is 25.1%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 3VEON Ltd.this pageVEON | 54.4/100Thin evidence · provisional58% evidence | TURNING | 15.4/35 Revenue — · PAT — · OPM change 2.2 pp 45% evidence | 16.4/25 ROCE 5.9% · OPM 25.5% 76% evidence | 8.7/20 P/E 65.3× · PEG — 15% evidence | 13.9/20 RS sector 1.6% · RS bench -7.2% · 1Y -3.3%1 of 12 weeks ahead 100% evidence |
| Exact sum: 15.4 + 16.4 + 8.7 + 13.9 = 54.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 4Verizon Communications Inc.VZ | 53.8/100Thin evidence · provisional58% evidence | BASING | 16.3/35 Revenue — · PAT — · OPM change 0.1 pp 45% evidence | 13.4/25 ROCE 2.1% · OPM 23.9% 76% evidence | 9.8/20 P/E 11× · PEG — 15% evidence | 14.3/20 RS sector 3.5% · RS bench -5.7% · 1Y 8.6%0 of 12 weeks ahead 100% evidence |
| Exact sum: 16.3 + 13.4 + 9.8 + 14.3 = 53.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 5Kyivstar Group Ltd.KYIV | 53.6/100Thin evidence · provisional58% evidence | FADING | 12.5/35 Revenue — · PAT — · OPM change -1.9 pp 45% evidence | 16.1/25 ROCE 7.6% · OPM 35% 76% evidence | 9.1/20 P/E 24.5× · PEG — 15% evidence | 15.9/20 RS sector 6.1% · RS bench -2.7% · 1Y 32.1%11 of 12 weeks ahead 100% evidence |
| Exact sum: 12.5 + 16.1 + 9.1 + 15.9 = 53.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 6Charter Communications, Inc.CHTR | 51.8/100Thin evidence · provisional58% evidence | BASING | 17.3/35 Revenue — · PAT — · OPM change 0 pp 45% evidence | 16.6/25 ROCE 3.5% · OPM 23.6% 76% evidence | 11.2/20 P/E 3.7× · PEG — 15% evidence | 6.7/20 RS sector -26.7% · RS bench -33.3% · 1Y -40.3%0 of 12 weeks ahead 100% evidence |
| Exact sum: 17.3 + 16.6 + 11.2 + 6.7 = 51.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 7Iridium Communications Inc.IRDM | 51.2/100Thin evidence · provisional58% evidence | LEADER | 12.8/35 Revenue — · PAT — · OPM change -4.9 pp 45% evidence | 10.0/25 ROCE 1.4% · OPM 23.2% 76% evidence | 8.8/20 P/E 62.3× · PEG — 15% evidence | 19.6/20 RS sector 69% · RS bench 54.9% · 1Y 108.4%12 of 12 weeks ahead 100% evidence |
| Exact sum: 12.8 + 10 + 8.8 + 19.6 = 51.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 8Globalstar, Inc.GSAT | 50.7/100Mixed-positive evidence61% evidence | ASLEEP | 21.7/35 Revenue 11.9% · PAT — · OPM change 25.9 pp 62% evidence | 5.5/25 ROCE 0.4% · OPM 11.7% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 13.5/20 RS sector 32.6% · RS bench 21% · 1Y 194%6 of 12 weeks ahead 100% evidence |
| Exact sum: 21.7 + 5.5 + 10 + 13.5 = 50.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9AT&T Inc.T | 50.4/100Thin evidence · provisional58% evidence | BASING | 19.5/35 Revenue — · PAT — · OPM change 2.3 pp 45% evidence | 12.0/25 ROCE 1.9% · OPM 21.1% 76% evidence | 10.6/20 P/E 6.9× · PEG — 15% evidence | 8.3/20 RS sector -11% · RS bench -18.9% · 1Y -16.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 19.5 + 12 + 10.6 + 8.3 = 50.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 10Telefônica Brasil S.A.VIV | 48.6/100Thin evidence · provisional58% evidence | BASING | 20.5/35 Revenue — · PAT — · OPM change 1.2 pp 45% evidence | 13.8/25 ROCE 2.6% · OPM 15% 76% evidence | 9.6/20 P/E 16.6× · PEG — 15% evidence | 4.7/20 RS sector -10.7% · RS bench -18.8% · 1Y 1.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 20.5 + 13.8 + 9.6 + 4.7 = 48.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 11Array Digital Infrastructure, Inc.AD | 47.9/100Mixed-negative evidence64% evidence | BASING | 23.8/35 Revenue 6.9% · PAT — · OPM change 418.9 pp 62% evidence | 13.6/25 ROCE 2.4% · OPM 309.1% 76% evidence | 9.3/20 P/E 19.2× · PEG — 15% evidence | 1.2/20 RS sector -27.9% · RS bench -34.2% · 1Y -52.3%0 of 12 weeks ahead 100% evidence |
| Exact sum: 23.8 + 13.6 + 9.3 + 1.2 = 47.9 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -27.9% and the one-year return is -52.3%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 12Rogers Communications Inc.RCI | 46.5/100Thin evidence · provisional58% evidence | ASLEEP | 16.6/35 Revenue — · PAT — · OPM change -1 pp 45% evidence | 11.5/25 ROCE 1.5% · OPM 20.9% 76% evidence | 11.0/20 P/E 4× · PEG — 15% evidence | 7.4/20 RS sector -9.1% · RS bench -17% · 1Y -0.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 16.6 + 11.5 + 11 + 7.4 = 46.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 13T-Mobile US, Inc.TMUS | 45.9/100Thin evidence · provisional58% evidence | BASING | 16.1/35 Revenue — · PAT — · OPM change -3.5 pp 45% evidence | 14.1/25 ROCE 2.9% · OPM 19.5% 76% evidence | 9.4/20 P/E 17.6× · PEG — 15% evidence | 6.3/20 RS sector -16% · RS bench -23.3% · 1Y -27.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 16.1 + 14.1 + 9.4 + 6.3 = 45.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 14Comcast CorporationCMCSA | 43.8/100Thin evidence · provisional58% evidence | BASING | 14.1/35 Revenue — · PAT — · OPM change -5.8 pp 45% evidence | 12.0/25 ROCE 2.2% · OPM 13.1% 76% evidence | 10.2/20 P/E 7.9× · PEG — 15% evidence | 7.5/20 RS sector -13.5% · RS bench -21.2% · 1Y -21.3%0 of 12 weeks ahead 100% evidence |
| Exact sum: 14.1 + 12 + 10.2 + 7.5 = 43.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 15Telephone and Data Systems, Inc.TDS | 43.0/100Mixed-negative evidence64% evidence | BASING | 20.5/35 Revenue -0.7% · PAT — · OPM change 58 pp 62% evidence | 10.3/25 ROCE 1.4% · OPM 47.6% 76% evidence | 8.5/20 P/E 79.4× · PEG — 15% evidence | 3.7/20 RS sector -13.2% · RS bench -21% · 1Y -7.8%0 of 12 weeks ahead 100% evidence |
| Exact sum: 20.5 + 10.3 + 8.5 + 3.7 = 43 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16Lumen Technologies, Inc.LUMN | 43.0/100Mixed-negative evidence64% evidence | ASLEEP | 18.4/35 Revenue -6.8% · PAT — · OPM change 17.4 pp 62% evidence | 9.9/25 ROCE 2.1% · OPM 20.8% 76% evidence | 11.3/20 P/E 3.6× · PEG — 15% evidence | 3.4/20 RS sector -12.5% · RS bench -20.2% · 1Y 78.5%6 of 12 weeks ahead 100% evidence |
| Exact sum: 18.4 + 9.9 + 11.3 + 3.4 = 43 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17EchoStar CorporationECHO | 40.5/100Mixed-negative evidence64% evidence | ASLEEP | 17.7/35 Revenue -5.6% · PAT — · OPM change 13 pp 62% evidence | 5.8/25 ROCE 0.9% · OPM 10.7% 76% evidence | 11.5/20 P/E 2.2× · PEG — 15% evidence | 5.5/20 RS sector -6.8% · RS bench -15.5% · 1Y 238.3%0 of 12 weeks ahead 100% evidence |
| Exact sum: 17.7 + 5.8 + 11.5 + 5.5 = 40.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Liberty Global Ltd.LBTYA | 35.4/100Thin evidence · provisional58% evidence | BASING | 12.6/35 Revenue — · PAT — · OPM change -3.3 pp 45% evidence | 4.0/25 ROCE 0% · OPM 1.9% 76% evidence | 10.9/20 P/E 4.6× · PEG — 15% evidence | 7.9/20 RS sector -6.3% · RS bench -14.5% · 1Y -1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 12.6 + 4 + 10.9 + 7.9 = 35.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 19TELUS CorporationTU | 29.4/100Thin evidence · provisional58% evidence | ASLEEP | 12.6/35 Revenue — · PAT — · OPM change -4.3 pp 45% evidence | 6.6/25 ROCE -3.3% · OPM 10.7% 76% evidence | 9.0/20 P/E 30.2× · PEG — 15% evidence | 1.2/20 RS sector -30% · RS bench -36.1% · 1Y -40.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 12.6 + 6.6 + 9 + 1.2 = 29.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 20Vodafone Group Public Limited CompanyVOD | 51.6/100Thin evidence · provisional44% evidence | ASLEEP | 18.7/35 Revenue — · PAT — · OPM change — 16% evidence | 7.8/25 ROCE 0.3% · OPM — 61% evidence | 10.1/20 P/E 9.5× · PEG — 15% evidence | 15.0/20 RS sector 12.6% · RS bench 2.6% · 1Y 38.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18.7 + 7.8 + 10.1 + 15 = 51.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 21Liberty Broadband CorporationLBRDA | 43.4/100Thin evidence · provisional45% evidence | BASING | 17.4/35 Revenue — · PAT -384.1% · OPM change 7.2 pp 10% evidence | 8.2/25 ROCE 0% · OPM 15.7% 76% evidence | 10.4/20 P/E 7.9× · PEG — 15% evidence | 7.4/20 RS sector -25.4% · RS bench -32.1% · 1Y -37.9%0 of 12 weeks ahead 100% evidence |
| Exact sum: 17.4 + 8.2 + 10.4 + 7.4 = 43.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is VEON Ltd.'s stock price today?
VEON Ltd. trades at $54.3, +7.5% over the past year. The company is valued at $4.0 B. The stock sits at 71% of its 52-week range of $44–$59, +4.7% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 2 weeks in. — as of 5 August 2026.
What were VEON Ltd.'s latest quarterly results?
VEON Ltd. reported revenue of $1.2 B and net profit of $0.1 B for the Mar 26 quarter. Revenue rose 16.5% and profit rose 0.0% year on year. Earnings per share were $1.50. The operating margin was 25.8%, 2.5 pp higher than a year earlier. — as of 5 August 2026.
What is VEON Ltd.'s revenue?
VEON Ltd. reported revenue of $1.2 B in the Mar 26 quarter, +16.5% year on year. For the full FY25 fiscal year, revenue was $4.4 B (+10.0%). Over the last 4 years revenue compounded at 3.4% a year. — as of 5 August 2026.
What is VEON Ltd.'s profit?
VEON Ltd. earned $0.1 B of net profit in the Mar 26 quarter, +0.0% year on year. Full-year FY25 profit was $0.6 B. The operating margin ran 25.8% in the latest quarter. — as of 5 August 2026.
What is VEON Ltd.'s market cap?
VEON Ltd.'s market capitalisation is $4.0 B at a stock price of $54.3. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.
Does VEON Ltd. pay a dividend?
No — VEON Ltd. has declared no dividend per share in any of its last 12 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 5 August 2026.
Is VEON Ltd. growing?
Yes — VEON Ltd. is growing: latest-quarter revenue +16.5% year on year, profit +0.0%, and the margin +2.5 pp at 25.8%. The 4-year compound rates are 3.4% (revenue) and 48.9% (profit). The earnings engine currently reads: improving — as of 5 August 2026.
How is VEON Ltd. performing?
VEON Ltd. is in a confirmed uptrend, 2 weeks in. Its latest quarter's revenue rose 16.5% and profit rose 0.0% year on year. Against the S&P 500 it has been ahead on a trailing-13-week view for 2 weeks. This describes what the data did, not a rating. — as of 5 August 2026.
What stage is VEON Ltd. in?
Mixed — no clean majority across the growth curves, ROCE lifting at 16.0% — the per-curve reads carry the story. The read comes from the last 12 quarters of growth (revenue growth +11.5% latest, profit growth +10.6% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 5 August 2026.
Is VEON Ltd. in an uptrend?
Yes — the price is in a confirmed uptrend (week 2 of stage 2), trading +4.7% versus its 200-day average and at 71% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 5 August 2026.
Is VEON Ltd. beating the market?
On recent form, yes — VEON Ltd. has been ahead of the S&P 500 on a trailing-13-week view for 2 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.1 years the stock moved −46% against the S&P 500's +263% — behind the index over the full window. — as of 5 August 2026.
Will VEON Ltd.'s stock price go up?
This page publishes no price forecast for VEON Ltd. What it measures instead: the stock price is $54.3, the price is in a confirmed uptrend 2 weeks in. Direction is not something this site claims to know. — as of 5 August 2026.
Does VEON Ltd. have too much debt?
It carries real leverage — VEON Ltd.'s debt-to-equity is 3.05. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. Read the returns on this page with that leverage in mind — as of 5 August 2026.
What is VEON Ltd.'s capex?
VEON Ltd. spent $2.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $0.7 B. — as of 5 August 2026.
What is VEON Ltd.'s cash flow?
VEON Ltd. generated $1.4 B of operating cash flow in FY25 and $0.6 B of free cash flow after $0.7 B of capital spending. Reported profit that year was $0.6 B, so operating cash ran ahead of profit. — as of 5 August 2026.
Is VEON Ltd.'s profit real cash?
Yes — over the last 3 fiscal years, 316% of VEON Ltd.'s reported profit arrived as operating cash. In FY25, operating cash was $1.4 B against reported profit of $0.6 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 5 August 2026.
How financially safe is VEON Ltd.?
On the balance sheet, the Z-score reads 0.70 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That is inside the danger band — a real balance-sheet risk. — as of 5 August 2026.
Where is VEON Ltd. in its business cycle?
VEON Ltd.'s FY25 operating margin was 32.7%, against a 5-year band of 25.1%–32.7%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 25.8%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.
What could break the VEON Ltd. story?
Biggest watch item: margins are the best this company has ever printed — every ratio flatters at record profitability, so the whole story leans on margins holding. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.
Is VEON Ltd. a stock worth studying right now?
This is not investment advice. The machine read: VEON Ltd.'s earnings have outrun its stock. EPS grew +30.4% in a year against a +7.5% price move. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.